New pharmaceutical supply chain intelligence from Panjiva tracks drug shipments and inventory activities
Alternative data set from S&P Global unlocks global supply chain connections in generic drug manufacturers
S&P Global Market Intelligence announced today the introduction of new alternative data set through its data feed management system, Xpressfeed™. This pharmaceutical package is a curated, sector-specific data feed that maps Panjiva supply chain data to the Food and Drug Administration's (FDA) Orange Book. This solution allows users to monitor and track pharmaceutical shipments to generic drug manufacturers leading up to official FDA announcements.
"This Panjiva Pharmaceutical data package is the foundation for benchmarking industry activity and providing insight into market changes, market entry, patent challenges, and inventory activities of generic drug manufacturers. The latest addition demonstrates our continuous commitment to bringing transparency to global supply chains," said Josh Green, co-founder of Panjiva.
Warren Breakstone, Managing Director and Chief Product Officer for Data Management Solutions at S&P Global Market Intelligence added, "This new source of alternative data offered via Xpressfeed provides new insights to investors and decision makers. Changes in shipment behaviour is a potential indication of FDA approval for generic distribution of drugs coming off patent and an important investment signal."
Panjiva's supply chain data was integrated to Xpressfeed in September of 2018.